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1. Introduction
Mosquitoes are the most menacing worldwide arthropod disease vectors. They transmit a
broad range of viral, protozoan and metazoan pathogens responsible of the most devastating
human and animal diseases [1]. Among the main frequent mosquito-borne diseases, malaria
represents the most widespread and serious infection in terms of heavy burden on health and
economic development throughout the world. Despite substantial efforts and increasing
international funding to eliminate it, malaria is still a major public health problem with nearly
a million of deaths per year, especially in children younger than 5 years old (86%) [2]. Ap‐
proximately two thirds of the world's population live in areas at risk for malaria [3, 4].
Understanding mechanisms that govern its transmission remains therefore a major scientific
challenge, but also an essential step in the design and the evaluation of effective control
programs [5, 6].
Entomological, parasitological and clinical assessments are routinely used to evaluate the
exposure of human populations to Anopheles vector bites and the risk of malaria transmission.
However, these methods are labor intensive and difficult to sustain on large scales, especially
when transmission and exposure levels are low (dry season, high altitude, urban settings or
after vector control) [7, 8]. In particular, the entomological inoculation rate (EIR), the gold
standard measure for mosquito–human transmission intensity of Plasmodium, is highly
dependent on the density of human-biting Anopheles [9]. This latter is estimated by using
trapping methods such as human-landing catches (HLC) of adult mosquitoes, the commonly
used for sampling host-seeking mosquitoes and then for assessing the human exposure level.
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HLC may be limited because of ethical and logistical constraints to relevantly apply it to
children [10]. Transmission estimates based on the prevalence or density of human infection
are susceptible to micro-heterogeneity caused by climatic factors and the socioeconomic
determinants of the host-seeking behavior [8]. Incidence of disease may be the closest logical
correlate of the burden of disease on health systems. However, it can be subject to variability
between sites and may not be appropriate for the evaluation of early phase studies of vector
control or reliable for epidemic prediction [10]. More recently, serological correlates of
transmission intensity have been described, yet they represent long-term rather than short-
term exposure data [8]. They are not then suitable in evaluating the short-term impact of vector
control programs. Therefore, it is currently emphasized the need to develop new tools
assessing reliably human malaria risk and control interventions, and monitoring changes over
time at both population and individual levels [5, 6].
Malaria is a parasitic disease caused by protozoan agents of the genus Plasmodium (Aplicom‐
plexa; Haemosporida). Five Plasmodium species are pathogen for humans: P. falciparum, P. vivax,
P. ovale, P. malariae and P. knowlesi. During their complex life cycle in the female Anopheles
mosquito (Insecta; Diptera), Plasmodium parasites go through several developmental transi‐
tions, traverse the midgut and reach the salivary gland (SG) epithelium. They acquire their
maturity within SGs of the vector and can be then transmitted by the bite of the female
mosquito. This latter needs, during the first days after emergence, to feed on sugar to meet the
energy demands of basic metabolism and flight, but also to feed on vertebrate blood for its
eggs’ development and maturation [11], and therefore to keep perennial its life cycle and
indirectly malaria transmission cycle.
Anopheles mouthparts comprise six pieces that form a long stylus allowing to perforate human
tissues and to suck the internal liquid. However, it is clear that Anopheles mosquito acts not
only as syringe injecting parasites during the bite. When taking a blood meal, it also injects
into human skin avascular tissue [12] a cocktail of bioactive molecules including enzymes that
are injected in human skin by saliva [13, 14]. Some of these salivary compounds are essential
to the Plasmodium life cycle [15]. They have substantial anti-hemostatic, anti-inflammatory, and
immunomodulatory activities that assist the mosquito in the blood-feeding process by
inhibiting several defense mechanisms of the human host [16]. Furthermore, many of them are
immunogenic and elicit strong immune responses, evidenced by the swelling and itching that
accompany a mosquito bite [17]. Specific acquired cellular [18, 19] or/and humoral responses
are developed by human individuals when exposed to bites of Anopheles mosquitoes [20-23].
These immune responses may play several roles in the pathogen transmission ability and the
disease outcomes [24]. In addition, recent studies have demonstrated that the intensity of the
antibody response specific to salivary proteins could be a biomarker of the exposure level of
human to Anopheles bites [22, 25]. Therefore, studying Anopheles-human immunological
relationships can provide new promising tools for monitoring the real human-Anopheles
contact and identifying individuals at risk of malaria transmission. It can also allow the
development of novel methods for monitoring control and mosquito-release programmes’
effectiveness.
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However, whole saliva could be inadequate as a biomarker tool, because it is a cocktail of
various molecular components with different nature and biological functions. Some of these
elements are ubiquitous and may potentially cause cross-reactivities with common salivary
epitopes of other haematophagous arthropods [26]. In addition, a lack of reproducibility
between collected whole Anopheles saliva batches has been observed and difficulties to obtain
sufficient quantities needed for large-scale studies were highlighted [26]. Therefore, specific
and antigenic proteins have been identified in the secretome of Anopheles mosquitoes and a
specific biomarker of Anopheles bites was developed by coupling bioinformatic and immuno-
epidemiological approaches. This promising candidate, namely, the gSG6-P1 (An. gambiae
Salivary Gland Protein-6 peptide 1), has been described to be highly antigenic [26]. It has been
then validated as a pertinent biomarker assessing specifically and reliably the exposure level
to Anopheles bites [27-29] and/or the effectiveness of malaria vector control [30] in all age-classes
of human populations (newborns, infants, children and adults) from several malaria epide‐
miological settings (rural, semi-urban and urban areas…) throughout sub-Saharan Africa
countries (Senegal, Angola and Benin).
The present chapter contributes therefore to a better understanding of the human-mosquito
immunological relationship. It resumes most of the studies highlighting the roles of mosquito
saliva on the human physiology and immunology, approaches, techniques, and methods used
to develop and validate specific candidate-biomarkers of exposure to Anopheles bites and their
applications on malaria control in several different epidemiological settings. Effects of various
explanatory variables (age, sex, seasonality, differential use of vector control…) on human
antibody responses to Anopheles salivary antigens are also discussed in the aim to optimize
their use in epidemiological and vector-borne disease (VBD) control studies. Finally, different
ways of application of such salivary biomarker of exposure of Anopheles vector bites in the field
of operational research by National Malaria Control Programmes (NMCP) are highlighted.
2. Human host-mosquito relationship: Roles of mosquito saliva
Arthropods represent the vast majority of described metazoan life forms throughout the world,
with species’ richness estimated between 5 to 10 million [31]. The blood feeding habit has arisen
and evolved independently in more than 14,000 species from 400 genera in the arthropod
taxonomy [32]. In mosquitoes, only the adult female is hematophagous, whereas both male
and female take sugar meals [33]. During the probing and the feeding stages, like all blood-
sucking arthropods, female Anopheles must circumvent the highly sophisticated barriers
represented by human defense systems (Fig. 1): haemostatic and inflammatory reactions,
innate and adaptive immune system defenses. Therefore, they express in their saliva potent
pharmacological and immunogenic components.
2.1. Pharmacological properties of mosquito saliva
The first-line of the human host non-specific defense to the insect bite is the haemostatic
reaction. It provides an immediate response to the vascular injury caused by the intrusion of
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the mosquito mouthparts in host vessels, thus preventing the extensive loss of host blood [32,
34]. The haemostatic reaction consists of three not physiologically distinct mechanisms: i) the
blood coagulation that leads to the production of fibrin clots, ii) the thrombus formation and
wound healing mediated by platelet aggregation, and iii) the vasoconstriction that leads to
restricted influx of blood to the injured site. Each mechanism is activated by several pathways,
in response to different exogenous and endogenous stimuli. Platelet aggregation is the first
step in the haemostatic cascade and follows the interaction between blood platelets and the
exposed extracellular matrix. This latter contains a large number of adhesive macromolecules
such as collagen which is abundant underneath endothelial cells (not found in blood). This
interaction results to the activation of platelets by mainly collagen and adenosine diphosphate
(ADP, released by damaged cells and by activated platelets), the primary agonists of platelet
aggregation. Platelets can be also activated by other agonists such as thrombin (produced by
the coagulation cascade) and thromboxane A2 (TXA2, produced by activated platelets) [35].
Activated platelets release endogeneous secretions such as serotonin and TXA2, two potent
vasoconstrictors. In parallel, the blood coagulation mechanism is getting underway. The main
task of the coagulation cascade is to produce fibrin that supports aggregated platelets in a
thrombus formation. The coagulation process consists of an enzymatic cascade with two ways
of activation, the exogenous and the endogenous, where several amplification points and
regulatory mechanisms are known.
Figure 1. Effects of Anopheles saliva on hemostatic, inflammatory and immune reactions of the human to the vector
bites.
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However, mosquitoes can successfully engorge on their hosts within a half-minute because
antihemostatic components of their saliva facilitate location of blood vessels and the blood
sampling [36]. These salivary secretions, named sialogenins (from the Greek sialo, saliva; gen,
origin, source; and ins for proteins), are mainly an array of potent anticoagulants, anti-platelets,
vasodilators and anti-inflammatory substances [16, 32, 37, 38].
2.1.1. Inhibition of platelet aggregation
Compared to other blood-sucking arthropods like ticks and sand flies, only a limited number
of Anopheles mosquito sialogenins involved in the inhibition of platelet aggregation have been
characterized. Apyrase (Adenosine triphosphate (ATP)-diphosphohydrolase EC 3.6.1.5) is
ubiquitous for hematophagous arthropods (mosquitoes, bugs, sand flies, fleas, triatomines,
and ticks) and hydrolyses ATP and ADP into adenosine monophosphate (AMP) and inorganic
phosphate (Pi), thus inhibiting platelet aggregation [16]. Three classes of apyrase have been
characterized at the molecular level in different blood-sucking arthropods (reviewed by [39]).
One named 5′-nucleotidase family is highly expressed in the salivary gland of Anopheles
gambiae [40]. The D7 protein family is one of the most abundantly expressed sialogenins of
mosquitoes. Two classes have been described in the saliva of mosquitoes: long (28–30 kDa)
and short (15–20 kDa) forms [41-43]. The D7-related proteins may inhibit activation of host
plasma. It has been described in Anopheles mosquitoes in a short form and may block the
platelet activation by scavenging serotonin (agonist-positive feedback loop to increase platelet
aggregation), while it principal function is reported to modulate tonus of vessels (vasocon‐
striction) [44]. Anophelin from An. stephensi saliva is a 30-kDa protein that directly binds to
immobilized collagen and specifically inhibits collagen-induced platelet aggregation and the
intracellular Ca2+ increase [45]. It can also act by inhibiting the activity of thrombin which plays
a role in concentration of platelet aggregation [46].
2.1.2. Inhibition of blood coagulation cascade
Arthropod anticoagulants mostly target factor X-active (fXa), which plays a central role at the
nexus of the intrinsic and extrinsic pathways, as well as an ultimate role of thrombin in driving
production of fibrin from fibrinogen. However, Anopheles mosquitoes produce an anti-
thrombin [38]. In An. albimanus for example, Anophelin protein has been shown to be a potent
anticoagulant that acts as a specific and tight-binding thrombin inhibitor [46], blocking or
delaying then the clot formation process until blood meal completion [34]. In addition, a D7-
related protein of An. stephensi saliva has been characterized as an inhibitor of fXII [47].
2.1.3. Vasodilator effect on host blood vessels
In human, various types of endogenous vasoconstrictors (serotonin, TXA2, noradrenalin…) are
released few seconds after tissue injury in order to stop the blood flow locally at the bite site.
Diverse types of vasodilators have been characterized in the saliva of hematophagous
arthropods. Aedes mosquitoes use sialokinins that mimic the endogenous tachykinin substance
P which stimulate the production of nitric oxide (NO), a potent dilator of blood vessels [48,
49]. In contrast, the saliva of the adult female Anopheles mosquito has been shown to contain
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a myeloperoxidase with a vasodilator activity associated with a catechol oxidase/peroxidase
activity [50]. This latter drives the H2O2-dependent destruction of noradrenalin and serotonin,
two important endogenous vasoconstrictors [50]. In addition, some D7 proteins of Anopheles
have been described to bind to biogenic amines such as serotonin, histamine, and norepi‐
nephrine [44]. These strategies remove the human host’s ability to maintain vascular tone at
the bite site, resulting to a weak but persistent local vasodilatation [14].
2.2. Immunological effects of mosquito saliva
The tissue injury causes an immediate onset of acute inflammation and innate immunity,
which promote tissue repair, prevent colonization of the damaged tissues by opportunistic
pathogens and initiates adaptive immunity, which is more specific [51]. These responses
mobilize multiple elements such as phagocytes and antigen-presenting cells, cytokine-
producing cells, T and B lymphocytes (TL and BL) and complement (classical and alternative
pathways). It may result to the development of strong cell and humoral immune reactions,
thereby altering physiologically the environment at the bite site and leading to the rejection of
the blood-sucker [52]. The saliva of Anopheles mosquitoes (like blood-feeding arthropods in
general) has selected, during evolution, compounds that can counter these host responses by
modulating immune cells and cytokines’ production [52, 53]. This certainly allows mosquitoes
to complete successfully a blood meal in only few seconds. Immunomodulatory effects of
Anopheles mosquito saliva can therefore affect the transmission of pathogens and the devel‐
opment of associated pathologies [54]. Understanding the mechanisms which govern this
immunomodulation could then allow the development of new prevention tools or strategies
against malaria transmission [54-56].
2.2.1. Inhibition of host inflammatory reaction
The host  inflammatory reaction following tissue injury consists  of  the triple response of
Lewis: redness, heat and pain, triggering the awareness of the host to the blood sucker action
[16]. If redness and heat are ones of the direct consequences of the dilatation of blood vessels,
pain is induced by an increased vascular permeability under the effect of ADP, serotonin
and histamine released by platelets and mast cells, following activation of the fXII by tissue-
exposed collagen [16]. The fXIIa converts prekallikrein to kallikrein, which hydrolyzes blood
kininogen to produce the vasodilator peptide, bradykinin. This latter induces TNF-α (Tumor
Necrosis Factor alpha) release by neutrophils [57], which in turn stimulates the release of IL
(interleukin)-1β and IL-6 from various cell types. These cytokines contribute to the phenom‐
enon of hyperalgesia (increased sensitivity to pain) that accompanies inflammation. Host
inflammatory reaction to bites has been described as mast cells-dependent in individuals
bitten by Anopheles mosquitoes [58]. In contrast to ticks which need to be attached to their
host for several hours (tick Argasidæ) or weeks (tick Ixodidæ), mosquitoes take just few seconds
for  a  successful  blood  meal.  This  certainly  explains  the  poverty  of  anti-inflammatory
components  in  their  saliva  in  contrast  to  the  ticks’  one.  Nevertheless,  some  salivary
components  of  Anopheles  mosquitoes  can  inhibit  the  human  inflammatory  reaction.  In
particular,  a  16kDa D7 family proteins of  An. stephensi  (Hamadarin)  inhibits  the contact
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system by preventing the mutual  activation between the fXIIa  and the  kallikrein  in  the
presence of Zn2+ [47].
2.2.2. Modulation of host immune response
A role for arthropod saliva in modifying the outcome of transmission and infection is not a
novel idea introduced in the context of mosquitoes and malaria parasites.  The increased
pathogen infectivity in association with ticks, sand flies, and mosquitoes saliva has been
described  previously  [54].  If  ticks  that  take  a  long  time  to  engorge  must  additionally
necessitate in their saliva anti-inflammatory and immunosuppressive factors, rapidly feeding
dipterans, in particular mosquitoes and sand flies, clearly have evolved salivary factors that
directly modulate host immune defenses [52]. One possible explanation is that these molecules
have evolved because they have long-term beneficial effects for the populations rather than
to the individual at the time of feeding [24]. Although the molecular mechanisms by which
mosquito saliva induces alteration of the host immune response are unclear [59, 60], data
evidently demonstrate that effects depend on the global regulation of the Th1/Th2 cyto‐
kines’ balance, as it  has been described in sand flies/Leishmania  model,  the most studied
striking host-parasite vector system [61]. The Th1 response has been described to lead to a
protective immunity and the resistance of the host to intracellular pathogens, while the Th2
response might favor the survivor of pathogens (parasites, virus…) and then the disease
transmission and evolution [24]. For mosquitoes, studies have globally shown an enhance‐
ment of transmission and disease when pathogens are introduced in the presence of vector
saliva. Mosquito saliva is commonly associated with a downregulation of the expression of
Th1 and an upregulation of the Th2-type cytokines. In mouse models, mosquito saliva can
potentiate the infection of arboviruses [24, 62, 63]. The co-inoculation of Sindbis virus with
Aedes  aegypti  salivary  gland  extract  resulted  on  a  reduced  interferon-  gamma  (IFN-γ)
expression, when compared to injection of virus alone [64]. It has been also shown that Ae.
aegypti saliva contains multiple factors that can affect various components of the host immune
response  [65].  For  example,  factor  Xa  inhibitor  may  inhibit  complement  activation  and
leukocyte migration to the bite site [24] and other factors inhibit TNF-α release from activated
mast  cells  [66].  Chickens  subcutaneously  infected with  P.  gallinaceum  sporozoites  in  the
presence of Aedes fluviatillis salivary gland homogenates showed a higher level of parasitae‐
mia when compared to those that received only sporozoites [67]. For Anopheles, mice exposed
to mosquito feeding in tandem with the inoculation of sporozoites had higher parasitemia
and an elevated progression to cerebral malaria.  This was associated with,  in particular,
elevated levels of IL-4 and IL-10, suppression of overall transcription in response to infection,
and decreased mobility of dendritic cells and monocytes [19].  It  was also described that
Anopheles  stephensi  saliva  downregulates  specific  antibody  (Ab)  immune responses  by  a
mechanism that is mast cell and IL-10 -dependent [60]. IL-10, by inhibiting pro-inflammato‐
ry and Th1 cytokines, stimulates certain T, mast and B cells and has pleiotropic effects in
immunoregulation  and  inflammation,  while  IL-4  is  the  prototypical  Th2  cytokine  (it
differentiates CD4+ T-cells and up-regulates MHC class II production). The enhancement of
IL-10 expression could account for reduction in secretion of other cytokines because it inhibits
antigen presentation, IFN–γ expression, and macrophage activation [68].  However, some
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data  have  suggested  a  paradoxical  protective  role  of  mosquito  saliva  against  pathogen
transmission and disease infection. Ae. aegypti saliva can inhibit infection of dendritic cells
by dengue virus, and the pre-sensitization of dendritic cells with saliva prior to infection
enhanced this inhibition. Moreover, the proportion of dead cells was also reduced in virus-
infected dendritic cell cultures exposed to mosquito saliva, and an enhanced production of
IL-12 and TNF-α was detected in these cultures [69]. In addition to these effects on cellular
immunity, Anopheles saliva can also acts on humoral host immune response. Indeed, specific
antibodies (immunoglobulins [Ig] G, M and E) to salivary antigens have been described in
several studies [20, 22, 23, 25, 56, 70]. However, the implication of these Ab responses in
disease pathogenesis or protection is not yet elucidated.
Therefore, future studies are needed for an overall understanding of mosquito saliva effect,
especially Anopheles mosquito saliva, in pathogen transmission, disease development and
pathogenesis.
2.2.3. Human host-Anopheles vector immune relationship and applications
The study of immunological properties of salivary proteins of Anopheles mosquitoes represents
a new research thematic which can significantly improve the understanding of Plasmodium
transmission mechanisms and therefore help for the effective prevention and control of
malaria. It can notably lead to major applications in three areas: i) development of vaccines,
diagnosis, treatment, ii) prevention of allergies, and iii) development of biomarkers of
exposure to bites and malaria disease risk.
The development of parasite transmission-blocking vaccines, by stimulating the immune
response against the vector is an attractive alternative way for malaria control. Several studies
targeted the effect of Abs specific to the mosquito midgut antigens have shown promising
results [71-73]. The study of the immune response induced by vector saliva at the biting site
and its potential effect on the transmission and the development of pathogens suggests the
possibility to control parasite transmission by vaccinating the host with immunogenic salivary
compounds [54, 74]. In a mouse model, it has been shown that two salivary proteins (29 and
100 kDa) of the female An. gambiae can induce production of Ab which can block about 75%
of the invasion of An. stephensi salivary glands by P. yoelii sporozoites [75]. In addition, the
prior exposition to non infective An. stephensi bites induces a Th1 immune response with
increased production of IL-12 and IFN-γ. Its effect can subsequently limit future P. yoelii
infection (reduced rate of liver and blood parasites) and the development of cerebral malaria
in mouse [18]. In this context, saliva can be thought as a non-specific “adjuvant” which could
be effective at inducing a Th1-biased environment that is known to be protective against
malaria infection. However, the development of such vaccines is complex. For example, Ab
produced by immunization (with salivary proteins) must be ingested by the mosquito during
a bite, cross it midgut and digestive enzymes, migrate to the salivary glands, before they can
block the invasion by sporozoites. Nevertheless, the possibility to develop a pan-arthropod
vaccine has been recently demonstrated by another mechanism. Indeed, an immune response
directed to salivary proteins that adsorb to pathogens can turn the microorganism into an
innocent bystander of anti-salivary immunity as it has been recently reported in a salivary
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protein (Salp15) from the hard tick Ixodes scapularis [76] and vaccine candidate for the control
of Lyme disease [77]. Unfortunately, any hematophagous arthropod saliva-based vaccine has
not yet been tested on humans.
In the field of allergic reactions to salivary proteins of mosquitoes, the first studies were mainly
conducted in Canada and Finland. They concerned Aedes and Culex mosquitoes which express
a panel of allergens in their saliva during the blood feeding time [17, 56, 78]. These proteins
can thus be used in recombinant form, as diagnostic tool of the level of human exposure to
allergens or in immunotherapy injections for desensitization of human [56, 70, 79]. It exists yet
no study highlighting the presence and effect of allergens in the Anopheles mosquitoes’ saliva.
The study of immunological relationship between human-vector by quantifying specific Ab
responses to salivary proteins may also allow the identification and characterization of
biological markers for epidemiological assessment of the exposure of individuals and popu‐
lations to the Anopheles bites and thus to the risk of malaria transmission [22]. The development
of such biomarkers or indicators (see next chapter) can be a complementary alternative to
current referent entomological and parasitological methods which present several limitations
especially in low exposure/transmission contexts.
3. Development of biomarkers of human exposure to Anopheles bites and
indicators of malaria vector control effectiveness
3.1. Validation of concept with whole Anopheles saliva
To improve the fight against malaria and regarding numerous limitations described with
current entomological and parasitological tools, the World Health Organization (WHO) has
emphasized the need of new indicators and methods to evaluate, at individual and population
levels, the exposure level to Anopheles vectors and the effectiveness of vector control strategies.
One promising concept is based on the fact that mosquito saliva injected to the human host
during the vector bite is antigenic and can induce an adaptive humoral host response (see
Figure 1). Therefore, a logical positive correlation between the human exposure level to
Anopheles bites and human anti-mosquito saliva Ab level can be expected. In this way, anti-
mosquito saliva Ab response can be a pertinent epidemiological biomarker of human exposure
to vector bites.
The epidemiological importance of human exposure to the saliva of vectors has been firstly
described in Lyme disease [80, 81], leishmaniasis [82] and Chagas disease [83]. During the last
decade, studies have provided data on human exposure to anopheline saliva and its interaction
with malaria transmission. In particular, Remoue et al. [22] have shown that children living in
a seasonal malaria transmission region of Senegal developed IgG responses to An. gambiae
whole saliva (WS). Interestingly, these specific IgG levels were positively associated with an
increased rainfall and the Anopheles mosquito density, measured by referent entomological
methods. Indeed, an increase in the level of IgG was observed according to the Anopheles
aggressiveness and density in September (Figure 2), the peak of malaria transmission.
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Importantly, IgG response to An. gambiae WS can predict clinical malaria cases. Indeed,
children who developed a malaria attack in December had higher levels of anti-WS IgG in
September of the same year, i.e. three months before they develop the disease (Figure 3) [22].
Malaria morbidity
Sept. to Dec.
P= 0.046
n= 132 n= 89
0.0
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Figure 3. Anti-salivary IgG according to malaria morbidity. The results of individual absorbance (OD) values in Septem‐
ber are shown according to subsequent detection of clinical malaria for the age ≥1 year. Bars indicate the median val‐
ue for each group. Statistical significance between groups is indicated by a non-parametric Mann–Whitney U-test).
Anti-mosquito saliva Ab appeared transitional. Soldier travelers transiently exposed to An.
gambiae bites in endemic areas of Africa (especially Ivory Coast and Gabon) developed specific
Exposure level
(entomology)0.0
0.2
0.4
0.6
0.8
low highmoderate
Anti-saliva I gG
P< 0.01 P< 0.05
Figure 2. Anti-saliva IgG according to the intensity of exposure [22]. Individual absorbance (OD) values in September
are shown for the three groups with different levels of exposure. Bars indicate the median value for each group. Statis‐
tical significances between each group by non-parametric Mann–Whitney U-test are indicated.
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IgG responses to anti-An. gambiae WS which strongly decreased several weeks after the end of
their trip [21]. In addition, anti-An. gambiae saliva IgG levels waned rapidly after 6 weeks of
Insecticide-Treated Nets (ITNs) well-use in a semi-urban population in Angola, before a new
significant increase two months later following the stop of ITN use [84]. Data on human
exposure to anopheline saliva and its interaction with malaria were also provided by studies
from other none African areas. In South-eastern Asia, it has been described that anti-An.
dirus salivary protein Ab occur predominantly in patients with acute P. falciparum or P. vivax
malaria; people from non-endemic areas do not carry such Abs [23]. In the Americas, the
presence of anti-Anopheles saliva Ab has been also described. In adult volunteers from Brazil,
anti-An. darlingi WS Ab levels increased with P. vivax infections [20]. The presence of anti-An.
albimanus WS Ab with exposure to mosquito bite has been recently described in Haiti [25].
Specific IgG response to An. gambiae WS has also been described as an immunological indicator
evaluating the efficacy of malaria vector control strategies. Indeed, Drame et al. have recently
shown in a semi-urban area (Lobito, Provence Benguela) in Angola that specific IgG levels
drastically decreased after the introduction of ITNs and this was associated with a drop in
parasite load (Figure 4) [84].
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Figure 4. Evolution of anti-Anopheles gambiae saliva IgG and Plasmodium falciparum infections before and after ITN
implementation, (Ano=Anopheles).
Anti-Anopheles saliva IgG response has also been recently used to evaluate and compare the
effectiveness of three malaria vector control strategies in another area (Balombo) of Angola [85].
Indeed, Brosseau et al. [85] have investigated over a period of two years (2008-2009) Ab response
to An. gambiae WS in children between 2 to 9 years old, before and after the introduction of three
different malaria vector control methods: deltamethrin treated long lasting impregnated nets
(LLIN) and insecticide treated plastic sheeting (ITPS) - Zero Fly®) (ITPS-ZF), deltamethrin
impregnated Durable (Wall) Lining (ITPS-DL - Zerovector®) alone, and indoor residual spraying
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(IRS) with lambdacyhalothrin alone. They observed considerable decreases in entomological
(82.4%),  parasitological  (54.8%)  and  immunological  criteria  analyzed.  In  particular,  the
immunological data based on the level of anti-saliva IgG Ab in children of all villages significant‐
ly dropped from 2008 to 2009, especially with LLIN+ZF and with IRS (Figure 5).
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Figure 5. Comparison of median values of the IgG antibody response to Anopheles saliva obtained before and after
implementation of each vector control method [85].
Taken together, these studies indicated that the estimation of human IgG Ab responses specific
to Anopheles WS could provide a reliable biomarker for evaluating the Anopheles exposure level,
the risk of malaria transmission, the disease outcomes and the effectiveness of vector control
strategies. However, the pertinence and the practical large-scale application of serological tests
for epidemiological purposes have been hampered by several limitations. First, WS is a cocktail
of various molecular components with different nature and biological functions. Some
components are Anopheles-specific and other widely distributed within genus, families, orders
or classes of bloodsucking Diptera or Arthropods [16]. Therefore, the evaluation of Anopheles
exposure or vector control effectiveness based on the immunogenicity of WS could be skewed
and over or underestimated by possible cross-reactivities between common epitopes between
mosquito species or other organisms [26]. Second, the collection of saliva or salivary gland
extracts is tedious and time-consuming; therefore it will be difficult or impossible to have an
adequate production of mosquito saliva needed for large-scale epidemiological studies [26].
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Third, saliva composition can be affected by several ecological parameters such as age, feeding
status or infectivity of Anopheles [86],which in turn may influence the anti-saliva immune
response measured and may cause a lack of reproducibility between saliva batches. An
alternative for optimizing the specificity of this immunological test would thus be to identify
Anopheles genus-specific proteins [87].
3.2. Methods for the identification of specific Anopheles salivary proteins
The isolation of salivary components has been a challenge for many years. Many functional
active salivary proteins have been isolated following classical biochemical and molecular
biology approaches [88]. Protocols mainly consisted of the isolation of salivary components
from hundreds of salivary gland pairs, obtaining amino-terminal or internal peptide sequence
of the purified component, screening of a salivary gland library with the information obtained,
and isolation of the cDNA or gene of interest (Fig. 6).
Activity detected on saliva or salivary gland 
homogenate (SGH)
Purificat ion of active component
Edman degradation of N-terminal part  or 
from internal peptide
Design degenerate primers based on 
obtained protein sequence
Produce PCR probe with designed primers
Screen salivary gland cDNA library
Secondary screen is usually performed to 
isolate cDNA of interest
Sequence cDNA of interest
Express recombinant protein either in bacteria, 
mammalian or insect cell-expression system
Test for biologic activity
Figure 6. Classical biochemical and molecular biology protocol used for isolation and characterisation of salivary pro‐
teins and cDNA from vectors of disease [90].
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During the last decade, technical advances in molecular biology have allowed the sequencing
of the genome, including transcripts of salivary glands [89], of most disease vectors, comprising
Anopheles mosquitoes [90]. However, protocols do not allow to obtain entire sequences [89].
Nowadays, researchers have switched from testing one salivary molecule at a time to studying
the whole complex of genes and secreted proteins in blood-feeding arthropods using tran‐
scriptomic and/or proteomic approaches. The transcriptomic is the complete set of transcripts
in an organism for a specific developmental stage or physiological condition. Transcriptomic
techniques help to interpret the functional elements of the genome, and to understand the
transmission and development of diseases [91]. They aim to catalogue transcript of major
Anopheles species, including mRNAs, non-coding RNAs and small RNAs; to determine the
transcriptional structure of genes and to quantify the changing expression levels of each
transcript during development and under different conditions [91]. Proteomic is a large-scale
study of the gene expression at the protein level, which ultimately provides direct measure‐
ment of protein expression levels [92]. The proteomic revolution is hitting the vector biology
field as well as many other fields. The isolation and sequencing of all the proteins from SGs of
disease vectors and, more specifically, secreted salivary proteins, is clarifying the complexity
of proteins present in the saliva of various blood-feeding arthropods [93]. During the last years,
a comprehensive high-throughput approach has been developed (Figure 7) [88]. It combines
massive sequencing protocol of high quality full-length salivary gland cDNA libraries, a
proteomic approach to isolate a large set of salivary proteins, and high-throughput computa‐
tional biology and functional assays to analyze and test the biologic activities of these novel
molecules. It is a powerful tool which can help easily and rapidly to identify and characterize
genes or transcripts encoding for various proteins of SGs (the sialome) of blood-sucking
arthropods. This high-throughput approach has then allowed an unprecedented insight into
the complexity of salivary gland compounds of mosquito vectors of disease agents, indicating
that the diversity of their targets is still larger than previously thought [16].
3.3. Salivary proteins (sialome) of Anopheles mosquitoes
The increasing power of large-scale genomic, transcriptomic and proteomic analyses allowed
the accumulation of a considerable amount of information on the salivary secretions of blood-
sucking arthropods [86]. As far as mosquitoes are concerned, the analysis of salivary tran‐
scriptomes of a number of Anopheles have allowed the discovery of a variety of genes that
matched the sequence of various protein families, providing some clues on the evolution of
blood feeding [15, 41-43, 92, 94-100]. Many of the salivary protein sequences are coded by genes
related to intrinsic functions of the cell (housekeeping genes). However, the large number of
salivary proteins is secreted during plant or blood feeding. Finally, a little number has no
similarities to sequences deposited in databases, representing unknown and novel sequences
[41, 94, 101]. This emphasizes how much still need to be learned concerning the biological
functions of salivary proteins in blood feeding, pathogen transmission and manipulation of
host responses.
The analysis of the adult Anopheles sialome has shown that secreted proteins and/or peptides
(secretome) can be ubiquitous or specific to arthropod classes, orders, families, genus or species
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[44, 101, 102]. In An. gambiae salivary gland females over 70 putative secreted salivary proteins
have been identified [94].
3.3.1. Ubiquitous salivary proteins
AG5 family proteins are found in the salivary glands of many blood-sucking insects and ticks
[102, 103]. In An. gambiae, four proteins belonging to this family were identified, but only one
(putative gVAG protein precursor) was coding for transcripts enriched in the adult female SGs
[94]. A precursor of gVAG protein was also described in An. funestus (84% sequence identity)
and An. stephensi (85% sequence identity) sialome [95, 100]. The function of any AG5 protein
in the saliva of any blood-sucking arthropod is still unknown.
Enzymes such as maltase, apyrase, 5′ nucleotidase, and adenosine deaminase, are also secreted
during the bite of many blood-sucking arthropods, including Anopheles mosquitoes [95]. They
generally assist in sugar feeding (maltase) or in degradation of purinergic mediators of platelet
aggregation (apyrase, 5′ nucleotidases) and inflammation (adenosine deaminase).
3.3.2. Salivary proteins found exclusively in Diptera
D7 family proteins are specific to SGs of blood-sucking Nematocera, including mosquitoes and
sand flies [104, 105]. They are highly represented in the sialome of Anopheles mosquitoes in
short and long forms [95, 96, 101, 104, 105]. An. funestus D7 proteins vary between 64% and
Construction of unidirectional full- length, PCR-based
cDNA library from small number of salivary glands
Random selection of phage plaques 
containing salivary gland cDNA inserts
PCR amplificat ion using primers from sequence of  
vector flanking the inserted salivary gland cDNA
Sequence of amplified PCR products
High-throughput computational biology to characterize
and sort  sequence
Creation of database from the sequence cDNA
Test predicted activity
on arthropod saliva
Prepare antibodies for functional
assaysusing DNA vaccination or 
recombinant protein
Express recombinant protein either in bacteria, 
mammalian or insect cell-expression system 
and test for predicted activity
Figure 7. Current high-throughput strategies used for the isolation and characterisation of salivary cDNA and proteins
from disease vectors [90].
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75% identity with their An. gambiae closest match [105]. D7 proteins could act as anti-hemostatic
factors by trapping agonists of hemostasis [44, 47]. However, further investigations are needed
to clearly describe their function.
Other Diptera-specific protein families or peptides have also been described in the sialome of
blood-feeding mosquitoes [95]. However their function is still unknown, even if some were
known to play a role in antimicrobial property of mosquito saliva.
3.3.3. Protein families found exclusively in mosquitoes
The 30-kDa antigen family found exclusively in the SGs of adult female mosquitoes has been
found in both culicine and anopheline mosquitoes [95, 100, 101, 106-108]. Only one gene
enriched in SGs of adult females is known in An. gambiae. The An. funestus homologue is also
abundantly expressed and shares 63% identity with the An. gambiae orthologue. The function
of this protein family is still unknown [95].
The gSG (An. gambiae Salivary Gland)-5 family was first discovered in the SGs of An. gambiae
and shown to be exclusively expressed in the adult female [94, 109]. This protein shows a high
similarity to Aedes and Culex proteins [101]. Transcripts coding for this family were found in
the sialotranscriptome of An. darlingi with 46% identical to the An. gambiae orthologue and
only 26% and 23% identical to the culicine proteins [101]. The function of this mosquito-specific
protein remains unknown, but its tissue- and sex-specific expression profile suggests it is
possibly related to blood feeding.
The gSG8 family is highly divergent with members only found in An. gambiae and Ae. aegypti.
In An. gambiae, this protein is specifically expressed in female SGs [109], suggesting a likely
role in blood feeding.
Various types of mucins have been described in the saliva of adult mosquitoes and may
function/act as a lubricant of their mouthparts [15, 41, 94, 102]. Three mucins encoding
transcripts have been identified in the An. gambiae larval SG [110], suggesting the importance
of mucins at multiple developmental stages. Mucins may also play a crucial role in Anophe‐
les salivary gland invasion by P. berghei sporozoites [111]. Several protein families are also
represented in this group, including gSG-3, gSG-10, and 13.5-kDa families [101]. These families
were also found abundantly expressed in the sialotranscriptome of An. gambiae adult male
[112], indicating their function is not related specifically to blood feeding.
3.3.4. Protein families found exclusively in Anophelines
Anophelin was described as a short acidic peptide with strong thrombin inhibitory activity in
An. albimanus [46]. An. funestus anophelin is 59% identical to the An. gambiae orthologue [95],
and An. darlingi anophelin is 86% identical to An. albimanus [101].
The 8.2-kDa family is represented in several Anopheles species. In An. funestus the peptide have
42% identity with the 8.2-kDa salivary peptide of An. stephensi and similar proteins from An.
gambiae and An. darlingi [95]. In An. gambiae, this peptide was found enriched in adult female
SGs, suggesting a role in blood feeding.
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The 6.2-kDa family was first described in a sialotranscriptome of An. gambiae [94], where it was
found enriched in adult female SGs compared to other tissues. The An. funestus member of this
family is 61% identical to the An. gambiae [95], and 53% to an An. darlingi [101] homologues.
The SG-1 family proteins appear to be exclusively expressed in the female SGs of Anopheles
mosquitoes and not observed in other tissues [94, 101]. However, their function remains to be
determined.
The SG-2 family proteins were identified from An. gambiae saliva and shown to be expressed
in female SGs and adult males but not in other tissues [113]. Related, but very divergent,
sequences were obtained from salivary transcriptomes of other anopheline species [95, 101].
Because this protein family is expressed in both male and female An. gambiae, and due to its
relatively small size, it may display antimicrobial function [101].
The hyp 8.2 and hyp 6.2 proteins are similarly enriched in An. gambiae adult female SGs [94]. An.
stephensi and An. funestus also have members of these protein families.
The SG-7/Anophensin family is also unique to anophelines. In An. gambiae, it is highly enriched
in female SGs [94]. More recently, the An. stephensi homologue was determined to inhibit
kallikrein and production of bradykinin, a pain-producing substance [114]. Four putative
alleles representing the homologue(s) of gSG7 in An. darlingi were identified. These An.
darlingi transcripts have no more than 45% identity to the An. gambiae gSG7 and An. stephensi
anophensin [101].
The SG6 protein is a small protein first described in An. gambiae [109] and a unique sequence
codes for a mature peptide/protein of ~10 kDa (116 amino-acids) with ten cysteine residues
making probably five disulphide bonds. A homologue was later found in the sialotranscrip‐
tome of An. stephensi [100] and An. funestus [95]. An. funestus SG6/fSG6 (f for funestus) has 81%
and 76% identities with An. stephensi and An. gambiae polypeptides, respectively. It is not found
in the transcriptomes of the Culicinae subfamily members analyzed so far, i.e. C. pipiens
quinquefasciatus, Ae. aegypti and Ae. albopictus [108, 115, 116]. In An. gambiae, the transcript
coding for gSG6 (g for gambiae) was found to be 16 times more expressed in SGs of adult females
than in males [94]. The gSG6 protein plays some essential blood feeding role and was recruited
in the anopheline subfamily most probably after the separation of the lineage which gave origin
to Cellia and Anopheles subgenera [99]. The gSG6 protein, because immunogenic, can be
therefore a reliable indicator of human exposure specific to Anopheles mosquito bites [99],
vectors of malaria.
3.4. Specific salivary biomarker of exposure to Anopheles bites: The gSG6-P1 peptide
candidate
The SG6 salivary protein has been reported to be immunogenic in travelers exposed for short
periods to Anopheles bites [21], and in Senegalese children living in a malaria endemic area by
an immuno-proteomic, coupling 2D immunoblot and mass spectrometry [117], and by an ELISA
[26] approaches. Recently, its immunogenicity has been confirmed in individuals from a malaria
hyperendemic area of Burkina Faso [118, 119], by using a recombinant form expressed as purified
N-terminal His-tagged recombinant protein in the E. coli vector pET28b(+) (Novagen) [99, 119].
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In particular, increased anti-gSG6 IgG levels were observed in exposed individuals during the
malaria transmission/rainy season [119]. In addition, anti-gSG6 IgG response appeared to be a
reliable serological indicator of exposure to bites of the main African malaria vectors (An. gambiae,
An. arabiensis and An. funestus) in the same area [119]. However, gSG6 recombinant protein has
been described to relatively generate a high background in control sera from individuals not
exposed to Anopheles bites, and considerable variations in specific Ab response between children
supposed to be similarly exposed to Anopheles  bites [26]. Therefore, with the objective of
optimizing Anopheles specificity and reproducibility of the immunological assay, a peptide
design approach was undertaken using bioinformatic tools [26].
3.4.1. Identification and sequence of gSG6-P1 peptide
Several algorithms were employed for prediction of potential immunogenic sites of the gSG6
protein by using bioinformatics. The prediction of immunogenicity was based on the deter‐
mination of physico-chemical properties of the amino-acid (AA) sequences with BcePred and
FIMM databases and on the identification of MHC class 2 binding regions using the ProPred-2
online service. This led to define five gSG6 peptides (gSG6-P1 to gSG6-P5) of 20 to 27 AA
Figure 8. Sequences of the anopheline gSG6 proteins [99]. (A) Clustal alignment of anopheline gSG6 proteins. Signal
peptides and conserved Cysteines are boxed. Conserved sites are shaded. (B) Phylogenetic tree (NJ algorithm, boot‐
strapped 10,000 times) constructed from the alignment of the nucleotide sequence encoding the mature gSG6 poly‐
peptides.
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residues in length (Fig. 9), overlapping by at least 3 residues and spanning the entire sequence
of the mature gSG6 protein. Both predictive methods for putative linear B-cell epitopes (FIMM
and BcePred) assigned the highest immunogenicity to gSG6-P1, gSG6-P2, gSG6-P3, and then
gSG6-P4.
MAIRVELLLAMVLLPLLLLESVVPHAAAEKVWVDRDNVY
CGHLDCTRVATFKGERFCTLCDTRHFCECKETREPLPYMY
ACPGTEPCQSSDRLGSCSKSMHDVLCDRIDQAFLEQ
gSG6-P1Signal Peptide
gSG6-P2 gSG6-P3
gSG6-P4 gSG6-P5
Figure 9. Amino-acid sequence of gSG6 Peptides. Amino-acid sequence of the SG6 protein of Anopheles gambiae (gi:
13537666) is presented and sequences of the selected peptides, gSG6-P1 to gSG6-P5, are underlined. Signal peptide
(SP) sequence is indicating by dotted underline [26].
Similarities were also searched using the Blast family programs, including both the
genome/EST libraries of other vector arthropods available in Vectorbase and of pathogens/
organisms in non-redundant GenBank CDS databases. No relevant identity was found with
proteins of other blood-sucking arthropods. Indeed, the longest perfect match was 6 AAs
between a putative protein from Pediculus humanus and gSG6-P2 and gSG6-P3 peptides. In the
case of gSG6-P1, the best match was 4 AAs in length with Culex pipiens quinquefasciatus salivary
adenosine deaminase. Moreover, no relevant similarity was found with sequences from
pathogens or other organisms. The highest hits of gSG6-P1 were with the cyanobacterium
Microcystis aeruginosa (3 AAs) and with Ostreococcus OsV5 virus (4 AAs). Altogether, this
analysis confirmed the bona fide high specificity of the five selected gSG6 peptides for the
Anopheles species. Peptides were then synthesized.
3.4.2. Antigenicity of gSG6 peptides
IgG Ab responses to the five gSG6 peptides were evaluated by ELISA in a randomly selected
subsample of children (n<30) living in a rural area of Senegal. All peptides were immunogenic,
but the intensity of the IgG level was clearly peptide-dependent; weak immunogenicity was
observed for gSG6-P3, gSG6-P4 and gSG6-P5, whereas gSG6-P1 and gSG6-P2 appeared highly
immunogenic (Fig. 10).
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IgG response to gSG6 peptides
Figure 10. IgG antibody response according to gSG6 peptides [26]. For each peptide, the IgG Ab level was evaluated in a
subsample of exposed children. Results at the peak of the season of Anopheles exposure are reported according to gSG6
peptides. Results are presented by box plot graph where lines of the boxes represent the 75th percentile, median and 25th
percentile of individual average ΔOD values; whiskers represent the lower and upper adjacent values.
3.4.3. Validation as a biomarker of exposure in several epidemiological settings
The specific IgG level to the two most antigenic gSG6 peptides (gSG6-P1 et gSG6-P2) was then
evaluated according to the level of exposure (estimated by entomological data) in a larger
sample (n=241) of children living in a malaria seasonal area [26]. A positive trend was found
for both peptides, but only significant for gSG6-P1 (Figure 11). Altogether, these results
indicated that only the IgG response to gSG6-P1 is suitable to be a pertinent biomarker of
exposure to Anopheles bites and thus to risk of malaria.
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Figure 11. IgG response to gSG6-P1 and gSG6-P2 according to intensity of exposure to Anopheles gambiae bites [26].
Individual ΔOD (Optical Density) values in September (peak of the season of Anopheles exposure) are shown for the
three different exposure groups. Results are presented for the same children (n=241) for gSG6-P1 (A) and gSG6-P2 (B).
Exposure groups were defined by entomological data. Bars indicate median value for each exposure group. Statistical
significance between the 3 groups is indicated (non-parametric Mann-Whitney U-test).
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Therefore, the gSG6-P1 was selected as the most pertinent candidate as marker of exposure.
Indeed, this peptide appeared to satisfy several requirements that an exposure biomarker
should fulfill. First, it thus far appears to be specific to Anopheles genus and therefore, no rel‐
evant cross-reactivity phenomena with epitopes from other proteins of arthropods or patho‐
gens would be expected. Second, because it is of a synthetic nature, it guarantees high
reproducibility of the immunological assay. Third, it elicits a specific Ab response which
correlates well with the level of exposure to An. gambiae bites.
3.4.3.1. Biomarker of Anopheles vector bites
As previously suggested, anti-gSG6-P1 IgG response was described as a biomarker of An.
gambiae bites in children living in Senegalese villages where malaria transmission seasonally
and moderately occurred [26]. In the same area, a specific IgG response to the peptide has been
detected in 36% of children living in villages where very few An. gambiae, or none, were
collected by classical entomological methods [28]. This deals with a high sensitivity and
specificity of the gSG6-P1 epitope(s) after a low immunological boost induced by weak bites
exposure. This result points to the potential use of such serological tool as an epidemiological
biomarker of An. gambiae bites in very low exposure areas, where the sensitivity of current
entomological methods of malaria risk assessment is weak.
One study aimed to evaluate the risk of malaria transmission in children and adults living in
urban area of Senegal (Dakar region) by using the gSG6-P1 peptide biomarker. Results showed
considerable individual variations in anti-gSG6-P1 IgG levels between and within districts, in
spite of a context of a global low Anopheles exposure level and malaria transmission [27].
Despite this individual heterogeneity, the median level of specific IgG and the percentage of
immune responders differed significantly between districts. In addition, a positive association
was observed between the exposure levels to An. gambiae bites, estimated by classical ento‐
mological methods, and the median IgG levels or the percentage of immune responders
reflecting the real contact between human populations and Anopheles mosquitoes [27].
Differences in exposure levels to An. gambiae bites could then partly explain district and/or
group-variations in anti-gSG6-P1 IgG Ab response as previously described in a low-exposure
rural area of Senegal [28]. Interestingly, in urban Dakar area, immunological parameters
seemed to better discriminate the Anopheles exposure level between different groups compared
to referent entomological data. Moreover, in this study, some discrepancies were observed in
the correlation between immunological parameters and the exposure level to An. gambiae bites
assessed by entomological data in districts. This suggests the main role of the human behavior
influencing the contact with vectors. A differential use of Vector Control Measures (ITNs,
sprays, curtains) can for example drastically reduce human-vector contact. Many household
characteristics (height, type, use of air conditioning, well-closed windows), which can differ
between districts, could also be crucial factors. Importantly, the effect of these factors may be
not taken into account by assessing the mosquito exposure level and malaria risk with classical
entomological tools. This strengthens the usefulness of such biomarker as an alternative tool
in the evaluation of exposure levels to Anopheles bites, especially in low/very low exposure,
where current entomological methods can give inaccurate estimations of the human-mosquito
contact [27].
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In a population from a malaria hyperendemic area of Burkina Faso, the use of gSG6 recombi‐
nant protein as reliable indicator of exposure to the 3 main African malaria vectors (An. gambiae
s.s., An. arabiensis and An. funestus) has been suggested [119]. This probably could be relied to
a wide cross-reactivity between SG6 sequences of principal Anopheles vectors, which highly
share identical epitopes between species. Moreover, the gSG6-P1 peptide has been used to
accurately evaluate the exposure level to An. funestus bites in a rural area in Senegal [29].
Indeed, two-thirds of 2-9 years old children from this area developed an IgG response to gSG6-
P1, in an area where An. funestus only was reported. In addition, IgG response increased during
the An. funestus exposure season, and a positive association was observed with the level of
exposure to An. funestus bites [29]. This result deals with the cross-reactivity between An.
gambiae gSG6-P1 and An. funestus fSG6-P1 sequences which share a high level of identity.
Indeed, these sequences differ only by the substitution of two AAs: asparagine by glutamine
(position 9) and leucine by isoleucine (position 15) (Fig. 12).
Figure 12. Sequences of the SG6-P1 salivary peptide [29]. Sequences are shown for An. funestus (fSG6-P1), for An.
gambiae (gSG6-P1). Identities are marked with ‘*’ and strong AA conservations with ‘:’.
AAs from fSG6-P1 are close in terms of polarity and charge to those from An. gambiae gSG6-
P1. The main consequence is that individuals exposed to An. funestus bites can sufficiently
develop a specific Ab response against gSG6-P1 An. gambiae antigen. This observation, in
conjunction with present results, suggests that these substitutions do not alter the synthesis
and the recognition of specific Ab because epitope appears to be conserved.
All mentioned studies were conducted on subjects older than 1 year. However, to be more
relevant in epidemiological surveys and studies on malaria, such biomarker tool must
pertinently be applicable to all human age-classes, including newborns and young infants (<1
year old) who can be also bitten by Anopheles and at high risk of malaria transmission [120]. In
this way, a recent study has indicated that human Ab responses to gSG6-P1 biomarker help
to assess Anopheles exposure level and the risk of malaria in younger than 1 year old infants
living in moderate to high transmission area of Benin (Drame et al., submitted).
Indeed, the presence of anti-gSG6-P1 IgG and IgM in the blood of respectively 93.28 and 41.79%
of 3-months old infants (the majority of infants) and their gradual increasing levels until 12
months (Fig. 13), whatever the Anopheles exposure level or the season. These observations are
consistent with the development and maturation patterns of the newborn immune system
during the first months of life. Indeed, the immature human immune system completes its
maturation during infancy following exposition to antigens. Therefore, newborns are naive
and increasingly susceptible to infectious agents; their immune system is not or insufficiently
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stimulated by antigens. In endemic malaria transmission area, they are progressively exposed
to salivary antigens of Anopheles [121], probably explaining the progressive increase of anti-
gSG6-P1 IgG and IgM from 3 to 12 months-old. Individual or population factors and behaviors
enhancing the level of the human-Anopheles contact with age can play a crucial role on
accelerating this gradual acquisition [122, 123].
3.4.3.2. Factors of variation of antibody response to gSG6-P1 and their consequences
Specific gSG6-P1 Ab responses can be influenced by several determinant factors in their
variations between individuals, districts, villages, regions... Therefore, identifying effects of
human intrinsic (gender, age…) and extrinsic (period of sampling, use of vector control
measure…) factors will be useful to the application of the gSG6-P1 biomarker in epidemio‐
logical studies or monitoring, evaluation and surveillance of risk of malaria programmes.
Effect of age
Studies have globally reported an increasing anti-gSG6-P1 Ab level according to individual
age. In a moderate transmission semi-urban area in Angola, the lowest and highest specific
Figure 13. IgG and IgM responses to Anopheles gSG6-P1 salivary peptide in the first year-life. Individual IgG (A) and
IgM (B) responses to the Anopheles gSG6-P1 are represented for infants in months 3 (white), 6 (light-gray), 9 (dark-
gray) and 12 (black box) after their birth. Horizontal lines in the boxes indicate medians of the individual data. Hori‐
zontal black dotted lines represent the cut-off of IgG (0.204) and IgM (0.288) responder. Statistical significant
differences between all age groups (multivariate linear mixed model analysis) are indicated.
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IgG levels have been described in young children (0-7 years old) and in teenagers/ adults (>14
years old) respectively [30]. In a low malaria transmission urban area (Dakar region) in Senegal,
specific IgG levels were significantly higher in adults (>18 years old) compared to 6-10 years
old children and in this latter group compared to those aged from 2 to 5 years [27] [124]. In
Tori Bossito, moderate-high rural transmission area of Benin, both anti-gSG6-P1 IgG and IgM
levels were low at 3 months of age and gradually increased until 12 months after birth (Drame
et al., submitted). The increase of specific IgG response with age is consistent with the gradual
acquired immunity against Anopheles mosquito saliva [30] following the development of
individual factors and behaviors enhancing the probability of human-vector contact [122,
123]. However, few data have reported a decrease of IgG levels to gSG6-P1 peptide [28] or to
SG6 protein [118] with age. In particular, in Senegalese children (0 to 60 months old), the
highest specific IgG levels were reported in the youngest children in spite of a probable very
weak exposure to An. gambiae [30]. It can be explained by a passive IgG transfer from mother
to child during pregnancy or breastfeeding as recently reported in young infants from Benin
(Drame et al., submitted). This represents a way of overestimation of the assessment of human-
Anopheles contact level and the risk of malaria in young infants by using anti-gSG6-P1 IgG Ab.
Therefore, the evaluation of specific IgM Ab levels could be a relevant solution to bias in IgG
measurements. Indeed, IgM Ab, in a form of polymers (usually pentamers) in the human
organism, could not cross the maternal-foetal barrier [125] and are the first Ab to appear in
response to initial or primary exposure to antigen [126]. Interestingly, in Tori Bossito, specific
IgM levels seemed to be a serological marker only during the first 6-months of exposure. In
infants older to 6 months, the assessment of gSG6-P1-specific IgG showed a more pertinent
evaluation of exposure level.
Effect of sex
Some studies have reported higher levels of anti-gSG6-P1 in female individuals (children and
women) compared to males (children and men) [27, 30] ([124]; Drame et al., submitted).
However, this difference was not significant, suggesting that it might be only physiological.
The season of Anopheles exposure
The season of individual sampling may be also a factor of confusion in the use gSG6-P1 biomarker
in epidemiological studies on malaria risk assessment or control. Indeed, significant seasonal‐
ly variations in anti-gSG6-P1 IgG or/and IgM levels have been reported in studies conducted in
newborns, children or/and adults from endemic malaria areas in Senegal [27-29, 124], Angola
[30] and Benin (Drame et al., submitted). In Senegal, in particular, specific gSG6-P1 in urban
children and adults steadily waned from the beginning (October) to the end (December) of the
study, due to an important drop in human exposure level to An. gambiae s. l. bites from the end
of rainfalls (October) to the beginning of the dry season (December) [127, 128].
One direct application of a salivary biomarker of exposure could serve in the elaboration of
maps representing the risk of exposure to Anopheles bites. Such immuno-epidemiological
marker might represent a quantitative tool applied to field conditions and a complementary
tool to those currently available, such as entomological, ecological and environmental data [59,
129]. It could represent a geographic indicator of the risks of malaria transmission and thus a
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useful tool for predicting malaria morbidity risk as previously described [22]. Furthermore, it
may represent a powerful tool for evaluation of vector control strategies (impregnated bed-
net, intradomiciliary aspersion, etc.) and could here constitute a direct criterion for effective‐
ness and appropriate use (malaria control program) [84].
3.4.3.3. Indicator of malaria vector control effectiveness
Long and short-term evaluation of ITN efficacy
A longitudinal study associating parasitological, entomological and immunological assess‐
ments of the efficacy of ITN-based strategies using the gSG6-P1 biomarker has been conducted
in a malaria-endemic area in Angola. Human IgG responses to gSG6-P1 peptide were evalu‐
ated in 105 individuals (adults and children) before and after the introduction of ITNs and
compared to entomo-parasitological data. A significant decrease of anti-gSG6-P1 IgG response
was observed just after the effective use of ITNs (Fig. 14). The drop in gSG6-P1 IgG levels was
associated with a considerable decrease of P. falciparum parasitaemia, the current WHO
criterion for vector control efficacy [130]. It was particularly marked in April-August 2006,
corresponding to the season peak of An. gambiae exposure. Interestingly, the entomological
data indicated that this season-dependent peak was of similar intensity before (2005) and after
(2006) ITN use, suggesting ITN installation had no impact on An. gambiae density, probably
because of the low percentage of the overall human population covered in the studied area
[131]. This study indicated also that the drop of anti-gSG6-P1 IgG response was associated
with correct ITN use and not due to low Anopheles density. In addition, this was observed in
all age groups studied (<7 years, 7–14 years, and >14 years), suggesting that this biomarker is
relevant for ITN evaluation in all age groups. This rapid decrease after correct ITN usage
appears to be a special property of anti-gSG6-P1 IgG which is short-lived (4-6 weeks) in the
absence of ongoing antigenic stimulation, at/for all age classes.
The response does not seem to build up but wanes rapidly, when exposure failed. This property
represents a major strength when using such salivary biomarker of exposure for evaluating
the efficacy of vector control. In addition, using a response threshold (ΔOD=0.204) combined
with ΔODITNs - the difference between April (after ITNs) and January 2006 (before) - makes
possible the use of this operational biomarker at individual level (Fig. 15). The threshold
response (TR) represents the non-specific background IgG response (the cut-off of immune
response) and was calculated in non-Anopheles exposed individuals (n= 14- neg; North of
France) by using this formula: TR= mean (∆DOneg) + 3SD = 0.204. An exposed individual was
then classified as an immune responder if its ΔOD> 0.204. If the ΔODITNs value is comprised
between -0.204 and +0.204, no clear difference in exposure level to Anopheles bites can be
defined.
In contrast, if the individual ΔODITNs value <−0.204, it could be concluded with a high level
of confidence that this individual is benefiting from ITN installation. The ΔODITNs parameter
could therefore provide a measure of ITN efficacy at the individual level. An individual bio‐
marker would also be relevant at the large-scale operational studies or surveillance in the
field, e.g. in National Malaria Control Programs (NMCP). In addition, the high sensitivity
and specificity of the gSG6-P1 Ab response make it ideal for the evaluation of low-level ex‐
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posure to Anopheles bites [27, 28], even when exposure or transmission is curtailed by NMCP
efforts. Taken together, the estimation of human IgG responses to Anopheles gSG6-P1 could
provide a reliable indicator for evaluating the efficacy of ITN-based strategies against malar‐
ia vectors, at individual and population levels, even after vector control generating particu‐
lar low exposure/transmission contexts. This salivary biomarker is a relevant tool for the
evaluation of short-term efficacy as well as longer-term monitoring of malaria VCMs.
Evaluation of effectiveness of diverse vector control measures
A recent cross-sectional study conducted from October to December 2008 on 2,774 residents
(children and adults) of 45 districts of urban Dakar (Senegal) has validated IgG responses to
gSG6-P1 as an epidemiological indicator evaluating the effectiveness of a range of VCMs.
Indeed, in this area, IgG levels to gSG6-P1 as well as the use of diverse malaria VCMs (ITNs,
mosquito coils, spray bombs, ventilation and/or incense) highly varied between districts [124].
This difference of use suggests some socio-economical and cultural discrepancies between
householders as described in large cities of Ivory Coast [132] and Tanzania [123]. At the district
level, specific IgG levels significantly decreased with VCM use in children as well as in adults.
Figure 14. IgG Ab responses to gSG6-P1 before and after ITN use [30]. The percentage (%) of anti-gSG6-P1 IgG im‐
mune responders (thick-dotted line) in the “immunological” sub-population (n=105), before (2005) and after (2006
and January 2007) the installation of ITNs (A). These results are presented together with the intensity of P. falciparum
infection (mean parasitaemia – fine-dotted line) measured in the same population and the mean of number of An.
gambiae (solid line) in the studied area (A). Entomological data were not available in December 2006 and January
2007 (the last two months of the study). Arrows indicate the installation of Insecticide Treated Nets (ITNs) in February
2006. Individual anti-gSG6-P1 IgG levels (ΔOD) are presented before (2005) and after (2006) the installation of ITNs
(B). Bars indicate the median value for each studied month. Statistically significant differences between months are
indicated.
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Among used VCM, ITNs, the 1st chosen preventive method (43.35% rate of use), by reducing
drastically the human-Anopheles contact level and specific IgG levels in children as well as in
adults, were by far the most efficient whatever age, period of sampling or the exposure level
to mosquito bites. Spray bombs were secondarily associated to a decrease of specific IgG level,
due certainly to their power and fast knock-down action. But, their effects can be limited by
the non-persistence of used products and some socio-economic considerations [133]. In
addition, they only have been recently adopted and are more expensive in the majority of sub-
Saharan Africa cities [133], explaining their less frequent use (9.57% rate of use) in the Dakar
area. The non-effect of mosquito coil use is surprising, regardless to their well-adoption by
residents (36.68% of rate of use), but it can be explained by their power deterrent effect which
tends to push Anopheles vectors outside where they can remain active [133]. However, the
protection ensured by ITN use seemed to be insufficient because anti-gSG6-P1 IgG levels in
ITN users were specifically high in some periods of fairly high exposure to Anopheles bites.
Changes in An. arabiensis behaviour, the major malaria vector in the area, can also explain this
lack of protection. It can bite outside the rooms/ habitations with a maximal activity around
10.00 pm, when people are not in bed and ITNs not hanged [123]. Therefore, ITNs must be
associated to a complementary VCM for an effective protection against Anopheles bites.
Taken together, these results suggest that the assessment of human IgG responses to Anophe‐
les gSG6-P1 salivary peptide can provide a reliable evaluation of the effectiveness of malaria
vector control in urban settings of Dakar whatever the age, sex, level of exposure to bites or
period of malaria transmission. Therefore, this salivary biomarker can be used to compare the
effectiveness of different anti-malaria vector strategies in order to identify the most suitable
for a given area.
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Figure 15. IgG response to gSG6-P1 as biomarker for short-term ITN efficacy. Changes in individual IgG levels (ΔOD)
are presented between “just before” (January 2006) and “just after” (April 2006) ITN introduction (n=105; children
and adults) (A). The arrow indicates the installation of Insecticide Treated Nets (ITNs) in February 2006. Individual IgG
level changes from January (before) to April are presented (B) by individual ΔODITNs, value (ΔODITNs=ΔODApril06, -
ΔODJanuary06). The threshold of specific IgG responders (TR=0.204) is indicated (dotted line). Significant positive
(ΔOD>0.204) or negative (ΔOD<−0.204) changes are therefore individually presented.
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Comparing effectiveness of combined or not vector control measures
In parallel to an entomological and parasitological evaluation, IgG responses to gSG6-P1 were
also used to assess, in a randomized controlled trial in 28 villages in southern Benin, four
malaria vector control interventions: Long-Lasting Insecticide-treated Net (LLIN) targeted
coverage to pregnant women and children younger than 6 years (TLLIN, reference group),
LLIN universal coverage of all sleeping units (ULLIN), TLLIN plus full coverage of carbamate-
indoor residual spraying (IRS) applied every 8 months (TLLIN+IRS), and ULLIN plus full
coverage of carbamate-treated plastic sheeting (CTPS) lined up to the upper part of the
household walls (ULLIN+CTPS). Results from this study have shown that specific IgG levels
were similar in the 4 groups before intervention and only significantly lower in the ULLIN
group compared to the others after intervention. In contrast to immunological data, clinical
incidence density of malaria, the prevalence and parasite density of asymptomatic infections,
and the density and aggressiveness of Anopheles mosquitoes, were not significantly different
between the four groups before as well as after interventions [134]. These findings mean that
LLIN used along by all the population of a given area may be more suitable in reducing the
contact between human populations and the Anopheles vectors, even if any effect on malaria
morbidity, infection, and transmission was not observed. Therefore, combining anti-vector
tools do not undeniably reduce individual exposure to malaria vectors, even if significant effect
on reducing more rapidly malaria transmission and burden has been reported [135]. These
findings confirm that anti-vector saliva Ab response as a biomarker of exposure is also
important for NMCPs and should help the design of more cost-effective strategies for malaria
control and elimination.
3.4.4. Importance to develop a specific biomarker of infecting Anopheles bites
Recent data have shown that the use of the gSG6-P1 biomarker for the assessment of the
differential risk of the disease transmission may have some limitations in high exposure areas
(Drame et al., submitted). Indeed, the gSG6-P1 assesses the exposure level to both infective and
not infective Anopheles bites. In malaria hyperendemic areas, resident people are highly
exposed to mainly not infective bites and present almost all Ab specific to gSG6-P1 levels
relatively high. Therefore it should be relevant to develop a biomarker of exposure specific to
infective bites in order to assess the human risk of malaria transmission in such contexts. Such
epidemiological parameter would be important to define in the context of malaria control. The
transmission depends on the density of competent Anopheles, of their Plasmodium infective rate
and of the intensity of human-vector contact. In addition, current methods to measure the
intensity of malaria transmission show several limitations, especially in low transmission
areas. The EIR (entomological inoculation rate) is a commonly used metric rate that estimates
the number of bites by infectious mosquitoes per person per unit time. It is the product of the
"human biting rate" – the number of bites per person per day by vector mosquitoes – and the
fraction of vector mosquitoes that are infectious (the "sporozoite rate"). The classical method
to estimate the density of sporozoites in mosquitoes is the dissection of salivary glands and
the sporozoites counting under microscope. But in area of low exposure and because few
mosquitoes are infected, many mosquitoes must be caught and dissected. The salivary glands
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dissection is a tedious technique which required well trained and studious personnel. More‐
over this technique cannot differentiate Plasmodium species. Another technique named CSP-
ELISA detects the CSP (Circumsporozoite protein) parasite surface protein and is generally
done on head/thorax of mosquitoes. However the CSP protein is expressed at the oocyst stage,
consequently the CSP can be detected in the mosquito before the sporozoites have reached the
salivary glands (until 2-3 days) [136, 137]. Therefore, this method induced a bias with an
overestimation of sporozoites index [138, 139]. Other traditional epidemiological estimates
mainly based on parasitological tests are very sensitive and specific allowing the determination
of parasite species, but the examination of finger prick and thick blood smear is also labour
intensive and time-consuming requiring well trained staff for a reliable examination [140]. To
improve the measure of transmission, antibody responses against parasite proteins (CSP,
AMA1, MSP1, MSP3, etc…) could be used but several studies have highlighted limits of this
approach. Actually, people exposed to malaria can be seropositive during several months [141,
142], even after transmission has stopped [141] or in the context of low transmission [143]. So
by using this method we are not able to distinguish old and new infection which is particularly
important in the context of evaluation of the effectiveness of vector control program. Consid‐
ering these limits, these serological parameters seem inappropriate to assess the malaria
exposure at the individual level. Some proteomic and transcriptomic studies highlighted that
the composition of Anopheles salivary glands could be modified with the presence of Plasmo‐
dium parasite [15, 144, 145]. Therefore, the development of a biomarker specific of infective
bites based on the analysis of antibody response against salivary proteins should represent an
alternative method to assess the parasite transmission to the human.
The principle of biomarker of infective bites is based on the use of immunogenic salivary
protein like marker of transmission. The expression of some salivary proteins could be induced
or regulated when the salivary glands are infected. Therefore, if one of such protein presents
also immunogenic properties, we can probably use the specific immune response to this
protein like a marker of transmission in human. Such a biomarker will be also particularly
relevant in the context of re-emergence after malaria transmission reduction or in area of low
exposure. This tool will allow focusing the intervention (vector control strategies and drugs
distribution) on the most exposed and the most susceptible population.
4. Conclusions
In the present chapter, we have described the development of a biomarker (the An. gambiae gSG6-
P1 peptide) of Anopheles mosquito bites by using an original approach coupling bioinformatic
tools and immuno-epidemiological assays. Then, measurements of IgG level specific to gSG6-
P1 at individual as well as population level, represent a tool/biomarker for accurately evaluate
the level of human exposure to Anopheles bites and the risk of malaria in all age-classes of
populations (newborns, infants, children, adults) living in various settings (very-low, low,
moderate, and high malaria transmission areas) of rural, semi-urban and urban regions of
Senegal, Angola and Benin. In the majority of these areas, this biomarker appeared to be
promising and complementary to classical entomological methods, because it can give a reliable
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evaluation of the individual contact with anthropophilic Anopheles even if exposure to bites is
low/very low (urban area). Therefore, such biomarker would be particularly relevant in places
where malaria transmission is low, e.g. in foci of urban, high-altitude or seasonal malaria, and
in travelers in endemic areas. This chapter has also shown that the availability of such a biomarker
could allow the evaluation of the exposure to the main P. falciparum vectors (An. gambiae s.s., An.
arabiensis, An. funestus, An. melas) in Africa where different species of malaria vector co-inhab‐
it. One direct application of such a gSG6 peptide marker of exposure could be in the elabora‐
tion of maps representing the risk of exposure to Anopheles bites. It could represent a geographic
indicator of the risks of malaria transmission and thus a useful tool for predicting malaria
morbidity risk as previously described. Furthermore, it represents a powerful and reliable tool
for the evaluation of the effectiveness of vector control strategies. Such an indicator could also
represent an alternative to classical entomological-parasitological monitoring methods for
measuring and following the effectiveness of vector control strategies used by the National
Malaria Control Programmes in various settings across Africa. Finally, this biomarker ap‐
proach could be similarly applied to vector-control strategies for other mosquito-borne diseases
such as emergent or re-emergent arbovirus diseases and trypanosomiasis.
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